Enanta Pharmaceuticals ENTA Delivers Q1 2026 Beat EPS 045 vs 050 Expected TransCode Therapeutics RNAZ Q4 2024 Results Miss Estimates EPS 15064 vs 9168 Oragenics OGEN Q2 2023 Beat Revenue NA EPS Exceeds by Significant Nvidias LongTerm Case Why Own It Dont Trade It Still Holds Weight